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Abstract 
EFFECTS OF THE.REMOVAL OF ADHERENT AND PHAGOCYTIC CELLS 
ON THE SPLEEN CELL LYMPHOPROLIFERATIVE RESPONSE 
OF TUMOR-BEARING MICE 
by 
Aileen M. Hyde 
Cell-mediated immunity was investigated in two 
BALB/c mouse tumor systems using the lymphocyte 
transformation test with phytohemagglutinin as the mitogen. 
This lymphoproliferative response was quantitated using the 
Stimulation Index (SI). Spleen cells from mice injected 
with #51 cells, a chemically-transformed colon cell line, 
produced a SI value equal to that of normal mice. There was 
no evidence for suppressor cell activity in cell mixing 
experiments in which spleen cells from #51 cell-injected 
mice were mixed with spleen cells from normal mice. 
Following macrophage removal by Sephadex G-10 columns and 
carbonyl iron ingestion, there were no significant changes 
in the SI values for spleen cells from the #51 cell-injected 
mice. In contrast, spleen cells from mice injected with 
H238 cells, a herpes virus-transformed cell line, had a 
significantly lower SI value than that of normal mice. 
Suppressor cell activity was demonstrated in cell mixing 
experiments in which spleen cells from H238 cell-injected 
mice were mixed with normal spleen cells. Removal of 
adherent cells from spleen cells from H238 cell-injected 
mice by Sephadex G-10 columns restored the SI value to that 
of normal mice. An increased SI value was also seen after 
removal of phagocytic cells by carbonyl iron. These results 
suggested that cells with the functional properties of 
macrophages played an important part in the immuno-
suppression observed in the H238 tumor system. Comparison 
of the two macrophage depletion methods suggested that 
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INTRODUCTION 
Macrophages have been shown to serve at least 
three functions in tumor immunology. Their selective 
cytotoxicity to neoplastic cells has been demonstrated 
( 6, 20). They also have functioned as accessory cells in 
other host defense mechanisms (21,60). However, in many 
tumor systems, macrophages actually suppressed the immune 
response (1,7,8,10-13,15,17,19,22,23,25-27,29,30,34-36,44-
4 7, 5 0, 51 , 5 4-5 7, 5 9, 6 3 )··.· 
The lymphocyte transformation test (LTT) using the 
mitogen phytohemagglutinin (PHA) (37) has been used to 
decipher the- role of macrophages. It has been demonstrated 
that PHA is specifically a T-lymphocyte mitogen and that 
macrophages are essential for this reaction to occur 
( 14, 42, 48, 49) • The LTT has been a useful tool for tumor 
immunologists as many tumor systems have shown a depressed 
response that correlated with the immune status of the host 
and host tumor size (18,22,25,28,41,46,5Q,52,56,57,59,). 
Using this test, suppressor macrophages have been indirectly 
demonstrated in many tumor systems. This was usually 
accomplished by selectively removing these cells which 
thereby restored lymphoproliferation.to normal levels. 
Using the LTT as an assay, suppressor macrophages 
have been associated with tumors transformed chemically 
(24,44,46,50,55,59), virally (15,26,27,30,41,57), and 
2 
spontaneously (25,56,59). Suppressor macrophages have been 
demonstrated in spleen cells from tumor-bearing mice (25-
27,41,44,46,50,56), rats (22,52,55,57-59) and chickens (53). 
Using similar protocols suppressor macrophages have been 
identified in blood from cancer patients (9,29,34,54,63) 
suggesting potential clinical relevance of these animal 
studies. 
The non-specific action of suppressor macrophages 
has been indicated by similar results obtained in animal and 
clinical studies when using in vivo tests (8,11,23,35,36,61) 
and other in vitro immunological tests that measure the 
function of T-lymphocytes (1,2,7,10,12,16,17,19,30,33,47, 
51), B-lymphocytes (1,41,44,45,46,56) and natural killer 
cells (13). 
Splenomegaly has been shown to be a characteristic 
of many tumor-bearing animals (7,17,24,27,38,41,46,50,62). 
Of the tumor systems in which suppressor macrophages have 
been demonstrated, many also have shown splenomegaly 
(7,17,41,46,50,62). These include cell lines transformed by 
viruses (17,41) and chemicals (7,46,50,62). 
Our laboratory has been studying two BALB/c mouse 
tumor systems; one in which tumors are produced by injection 
of chemically-transformed cells (#51), and the other in 
which the tumors are produced as a result of injection of 
virally-transformed cells (H238) (18,38-40). With both 
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systems, tumor-bearing mice showed splenomegaly. The 
splenomegaly was more pronounced in the H238 system, with 
the relative spleen weight six times greater than normal 
(18); whereas in the #51 system, the spleens were twice the 
size of normal spleens (40). Furthermore, in the H238 
system, there was a depressed lymphoproliferative response 
to PHA correlating with tumor progression. Spleen 
stereology studies with H238 system showed an increase in 
the compact myeloid tissue, lymphoid nodule reaction 
centers, and red pulp volume (38). Suppressor macrophages 
have been demonstrated in another tumor system in which 
there was also in increased red pulp volume (24). In order 
to determine if suppressor macrophages were acting in the 
BALB/c mouse: H238 tumor cell system and in the BALB/c 
mouse: #51 tumor cell system, the effects of macrophage 
removal from spleen cells of tumor-bearing mice on the 
lymphocyte transformation test were monitored. 
MATERIALS AND METHODS 
Mice 
BALB/c mice were bred at our institution from mice 
originally purchased from The Jackson Laboratory (Bar 
Harbor, ME). The offspring were housed in groups of 6-8 in 
shoebox-type cages and fed Purina rodent laboratory chow and 
tap water ad libitum. At the time of injection with tumor 
cells, the mice were 18-20 weeks of age. 
Tumor Systems 
The H238 tumor was derived from a BALB/c mouse 
embryo skin cell line (238) transformed by ultraviolet 
light-irradiated herpes simplex virus type 2 (Savage strain) 
(3). The #51 tumor was derived from BALB/c mouse colon 
cells transformed in vivo by 1,2-dimethylhydrazine (4) and 
adapted for cell culture in our laboratory. The cells were 
stored in liquid nitrogen and grown in Dulbecco's medium 
supplemented with 10% fetal bovine serum before injection. 
The mice in each cage were divided into three groups and 
identified by marking with picric acid. By subcutaneous 
injection in the right thigh, one group received 1 x 106  
H238 cells in 0.3 ml tris-buffered saline (TBS), another 
group 1.6 x 105 #51 cells in 0.3 ml TBS, and the control 
group •was injected with 0.3 ml TBS only. At the time of 
sacrifice seven weeks later, all but two tumor-cell injected 
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mice had tumors. These two were excluded from the study. 
There was no evidence of tumors in the control mice. 
Lymphocyte Transformation Test  
5 For each experimental group, 2 x 10 viable spleen 
cells were cultured in eight replicate flat-bottom wells of 
a microtiter plate (Costar, Cambridge, MA). The culture 
medium consisted of RPMI-1640 supplemented with 20 mM HEPES 
buffer, 5.JRM 2-Mercaptoethanol, 10% heat-inactivated fetal 
bovine serum (56°C for 30 minutes), 100 U/m penicillin, 4 
mg/ml Streptomycin, 5,pg/m1 Fungizone and 1 U/ml Mycostatin. 
The four test wells received 0.28 pg of PHA (Burroughs 
Wellcome Co., Research Triangle Park, NC) in 0.1 ml 
RPMI-1640, whereas the four control wells received 0.1 ml of 
RPMI-1640. Five hours prior to culture termination, 1.0 
microcurie of 3H-thymidine (Research Products International 
Group, Mt. Prospect, IL, Spec. Act. 49.5 Ci/mM) in 0.05 ml 
RPMI-1640 was added to each well. After 48 hours of 
culture, the cells were harvested with a multiple sample 
harvester (Brandel, Gaithersburg, MD) and counted for 2 
minutes in, a liquid scintillation counter (Beckman, Los 
Angeles, CA). The Stimulation Index (SI) was calculated 
from the counts per minute (CPM) according to the following 
formula: 
Stimulation Index = Test CPM-Control CPM 
Control CPM 
6 
in which Test CPM represents average values for those wells 
which received PHA and Control CPM represents average values 
for those wells which did not receive PHA. 
Removal of Adherent Cells by Sephadex G-10 Columns  
The standard method (32) was adapted to use 12 ml 
disposable syringes as columns. A Sephadex G-10 slurry in 
0.85% saline was added to each syringe to give a 10 ml bed 
volume. The column was then rinsed with 25 ml of warm RPMI 
-1640 medium. A 2 ml suspension containing 1 x 108  viable 
spleen cells was added to the column and rinsed through with 
10.0 ml RPMI-1640. 
Removal of Phagocytic Cells by Carbonyl Iron Ingestion 
Viable spleen cells (1 x 108) from tumor-injected 
mice were suspended in 10 ml RPMI-1640 containing 100 mg 
carbonyl iron (Sigma, St. Louis, MO). After one hour of 
incubation at 37°C in a 5% CO2 incubator, cells containing 
carbonyl iron and excess carbonyl iron were retained with a 
6 lb. magnet and the remaining cells pipetted off. This 
process was repeated. 2-3 times. 
Enrichment of Adherent Cells by Petri Dish Adherence  
Viable spleen cells (5 x 106) were suspended in 2 
ml RPMI-1640 and plated into a 60 x 15 mm tissue culture 




37°Cina5%CO2  atmosphere, the 
nonadherent cells were pipetted off and the adherent cells 
were removed by scraping with a rubber policeman. 
Spleen Cell Differential Counts  
After straining with Wright's stain, a 100-cell 
differential count was done and the cells were classified as 
lymphocytes, granulocytes, or macrophages. 
Statistical Analysis  
The CPM values obtained from the lymphocyte 
transformation tests were subjected to the r method (5) of 
excluding outliers prior to calculation of the means for the 
stimulation index. 
The two-sided Student's t-test was used to compare 
groups. The p=0.05 level was chosen as the. level of 
significance. 
RESULTS 
Spleen Cell SI Values 
The spleen cells from the H238 cell-injected mice 
produced lower SI values than their normal counterparts in 
LTT assays; however, the spleen cell response of the #51 
cell-injected mice, though lower, was not significantly 
different from the normal response (Table 1). Comparing the 
spleen cell differential counts of normal mice with H238 
cell-injected mice showed an increase in granulocytes and 
macrophages (p=0.05) whereas the #51 cell-injected mice 
showed an increase only in the granulocyte population 
(p=0.05) (Table 2). 
Cell Mixing Experiments 
The ability of spleen cells to suppress the 
lymphoprolifera:tive -response of normal cells was examined in 
cell-mixing experiments. Spleen cells from #51 cell-
injected mice were not suppressive as there were no signi-
ficant differences in the SI values of various combinations 
of spleen cells from normal and #51 cell-injected mice 
(Figure 1). In contrast, spleen cells from H238 
cell-injected mice suppressed the SI values of normal spleen 
cells (Figure 2). The only exception was the mixture 
containing 90% cells from normal mice and 10% cells from 
H238 cell-injected mice in which the SI value was not 




Effects of Macrophage Removal and Reconstitution in the H238  
System 
Spleen cells from H238 cell-injected mice, after 
passage through the. Sephadex G-10 column, produced a SI 
value equal to that of normal spleen cells (Figure 3). 
Spleen cell differential counts showed that passage through 
Sephadex G-10 columns resulted in depletion of macrophages 
and granulocytes (Table 2). The reconstitution part of the 
experiment was designed to test for the presence of 
suppressor macrophages.. The hypothesis was that the 
addition of an enriched macrophage population to macrophage-
depleted cells would return the SI value to that of un-
treated spleen cells from H238 cell-injected mice. Adding 
back adherent spleen cells from both normal and H238 cell-
injected mice to the Sephadex G-10 nonadherent cells did not 
drop the SI value to that equal to untreated cells (Figure 
3). Spleen cell differential counts showed that there were 
no significant changes between the untreated population of 
spleen cells and the adherent spleen cells from both normal 
and H238 cell-injected mice (Table 2). As shown in Figure 
4, carbonyl iron nonphagocytic spleen cells from H238 cell-
injected mice had an elevated SI value not statistically 
different than that of normal cells but not significantly 
greater than that of the untreated population. Reconsti-
tuting the carbonyl iron nonphagocytic cells with normal 
10 
adherent spleen cells did not change the SI value from that 
of carbonyl iron nonphagocytic cells, whereas adding 
adherent spleen cells from H238 cell-injected mice lowered 
the SI value to that of the untreated population (Figure 4). 
Spleen cell differential counts showed that carbonyl iron 
treatment resulted in depletion of granulocyte and 
macrophage populations (Table 2). 
Effects of Macrophage Removal and Reconstitution in the #51  
System 
There were no significant changes in the response 
of spleen cells from #51 cell-injected mice following 
Sephadex G-10 treatment and reconstitution with adherent 
cells (Figure 5) or following carbonyl iron treatment with 
subsequent reconstitution with adherent cells (Figure 6). 
DISCUSSION 
Spleen cell differential counts from both groups 
of tumor-bearing mice showed a decreased percentage of 
lymphocytes in reference to normal mice. Both groups of 
tumor-bearing mice demonstrated splenomegaly. This splen-
omegaly was quantitated by determining the number of cells 
recovered per spleen. Compared to the number of spleen 
cells from normal mice, 451 cell-injected mice showed a 
three-fold increase and H238 cell-injected mice showed a 
seven-fold increase in number of cells. Furthermore, 
changes in spleen morphology in H238 cell-injected mice have 
been previously characterized by stereology studies in which 
it was shown that the splenomegaly was not due to increases 
in splenic connective tissue (38). Thus the decreased 
percentage of lymphocytes was due to a relative change in 
percentage of lymphocytes rather than an absolute decrease 
in total lymphocyte numbers. 
The SI values of spleen cells from mice with the 
chemically-induced tumor, #51, were not statistically 
different from those of normal mice. It was not surprising 
then that there were no differences between the mixtures and 
starting populations in the cell mixing experiments. 
Techniques used to remove and add back macrophages had no 
effect on the SI values produced by spleen cells from #51 
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cell-injected mice. With this assay, there was no evidence 
for suppressor macrophages in the #51 system. One cannot be 
certain, however, that suppression by macrophages was not 
involved in the #51 cell-injected tumor system. Since 
suppressor macrophages have been demonstrated in other 
chemically-induced tumor systems (7,46,50,62), it might be 
that the LTT assay system used was not sensitive enough to 
detect differences in the response of spleen cells from 
these mice compared with those from normal mice. 
In contrast, the SI values produced by spleen 
cells from mice bearing the virally-induced tumor, H238, was 
less than that of normal mice. To rule out that this 
suboptimal response of spleen cells from H238 cell-injected 
mice was an artifact resulting from a tumor-induced shift in 
the dose-response curve, PHA titrations with spleen cells 
from both normal and H238 cell-injected mice were done. 
Figure 7 shows that the SI values obtained depicted a 
bell-shaped curve as established in earlier work (31) and 
that the optimal concentration of PHA was the same for both 
sets of spleen cells. 
Cell mixing experiments have been used to detect 
active suppression from cells of tumor-bearing animals 
(41,44,46,56). Spleen cells from H238 cell-injected mice 
suppressed the lymphoproliferative response of normal cells 
(Figure 2). The data suggests that a critical number of 
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spleen cells from tumor-bearing animals were necessary for 
the suppression to occur. Suppression of the SI value of 
normal cells occurred only when spleen cells from H238 cell-
injected mice constituted 25% and 50% of the culture; 
whereas there was no suppression when the culture contained 
only 10% spleen cells from H238 cell-injected mice. 
When the spleen cell differential counts of H238 
cell-injected mice were compared with those of normal mice, 
the greatest change was found to be in the increase in per-
centage of granulocytes in the tumor-bearing mice. A likely 
candidate for a suppressor cell is a cell type increased in 
an immunosuppressed tumor-bearing animal. An unexpected 
finding in this series of experiments was that the tech-
niques chosen for macrophage removal were also effective for 
granulocyte depletion (Table 2). One can argue against 
granulocytes acting as suppressor cells in the H238 system 
by comparing our two tumor systems in which both showed 
granulocyte infiltration associated with tumor-bearing but 
immunosuppression only in the H238 system. There have been 
no reports in the literature of granulocyte-mediated sup-
pression. 
Macrophage removal techniques increased the SI 
values produced by spleen cells from H238 cell-injected 
mice. Cells that did not adhere to Sephadex G-10 columns 
produced a higher SI value than cells that did not 
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phagocytize carbonyl iron (Table 1). The only significant 
difference between these groups in the spleen cell 
differential counts was the percentage of macrophages (Table 
2). One interpretation of this data would be that all the 
macrophages functioning as suppressor cells have been 
removed in both methods. Sephadex G-10 columns have been 
shown to remove suppressor T lymphocytes (43). The 
augmented response of the Sephadex G-10 non-adherent cells 
might be due to the removal of another type of suppressor 
cell. 
In our reconstitution experiments, adding adherent 
cells back to cells that have been passed through Sephadex 
G-10 columns did not reduce the SI value. This protocol has 
been used by others to confirm that macrophages are 
functioning as suppressor cells (56). However, these 
investigators reported an adherent spleen cell population 
consisting of 95-99% macrophages. In contrast, we did not 
achieve an enriched macrophage population from our starting 
population in any of the three groups of mice (Table 2). 
With improved techniques yielding a higher percentage of 
macrophages, we would expect to see the SI values of both 
spleen cells of normal mice and Sephadex G-10 nonadherent 
spleen cells from H238 cell-injected mice reduced to that of 
spleen cells from 11238 mice. Spleen cells from 11238 
cell-injected mice that did not ingest carbonyl iron 
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responded quite differently to reconstitution with adherent 
cells (Figure 4). When normal adherent cells were added, 
there was no change in the SI value compared to that of the 
carbonyl iron treated cells; whereas when adherent spleen 
cells from H238 cell-injected mice were added the SI value 
was reduced to that equal to the starting population. 
Comparison of the SI values of the reconstituted 
cultures from macrophage-depleted spleen cells of H238 
cell-injected mice suggests a specific cellular interaction 
was needed for immunosuppression to occur. Figure 8 shows 
that of the four groups only the carbonyl iron treated cells 
reconstituted with adherent cells from spleens of H238 
cell-injected mice produced SI values significantly lower 
than that of 100% normal spleen cells. There was no 
suppression of the carbonyl iron nonphagocytic cells when 
reconstituted with adherent spleen cells from normal mice; 
but a significant depression when the same carbonyl iron 
treated cells were reconstituted with adherent spleen cells 
from H238 cell-injected mice. This suggests that 
tumor-induced adherent suppressor cell played a role in the 
immunosuppression. Comparing the response of cells not 
adhering to Sephadex G-10 columns, there was no difference 
between the SI values produced by cultures reconstituted 
with adherent cells from normal and H238 cell-injected mice. 
A possible explanation for the difference between the 
16 
response of reconstituted cultures from the two macrophage 
depletion methods is that the cell mediating the suppression 
was removed by the Sephadex G-10 columns. The carbonyl iron 
method removes phagocytic cells, i.e. granulocytes and 
macrophages, whereas the Sephadex G-10 columns remove 
adherent cells, i.e. macrophages, and nonspecifically T 
suppressor cells (43). Since macrophage removal was common 
to both methods, T suppressor cells seem to be a likely 
candidate for the 'cell interacting with the adherent cells 
from H238 cell-injected mice to produce the immuno-
suppression in the H238 system. 
The cellular mechanism for the suppression of the 
Iymphoproliferative response of H238 cell-injected mice is 
consistent with tumor-induced adherent cell, presumably a 
macrophage, interacting with T suppressor cells. Investi-
gations to test this model are now underway in our 
laboratory. 
TABLE 1. STIMULATION INDEX OF EXPERIMENTAL GROUPS 
Results of Five Replicate Experiments 
Experimental Group Mean Standard Error 
Baseline: 
1. Spleen Cells from normal Mice (N) 9.7 2.3 
2. Spleen Cells from H238 cell�injected Mice (238) 0.8 0.1 
3. Spleen Cells from #51 cell-injected Mice (#51) 3.9 1.1 
Cell Mixing Studies:
4. 50% N & 50% H238 3.3 0.7 
I-' 5. 75% N & 25% H238 3.3 1. 0
-,J 
6. 90% N & 10% H238 5.4 1. 3
7. 50% N & 50% #51 5.4 1. 3
8. 75% N & 25% #51 3.6 0.4
9. 90% N & 10% #51 5.8 2.0
Macr0Eha9e Studies: All wells contain 50% N plus :
10. 50% Carbonyl Fe Nonphagocytic H238 (CF-H238) 6.3 1. 7
11. 40% CF-H238 & 10% Normal Adherent 7.3 2.6
12. 40% CF-H238 & 10% H238 Adherent 3.5 1. 0
13. 50% Sephadex G-10 Nonadherent H238 (G-H238) 8.9 1. 8 
14. 40% G-H238 & Normal Adherent 6.9 1. 9
15. 40% G-H238 & 10% H238 Adherent 8.9 2.4
16. 50% Carbonyl Fe Nonphagocytic #51 (CF-# 51) 6.3 l. 8 
17. 40% CF-#51 & 10% Normal Adherent 6.6 2.0 
18. 40% CF-#51 & 10% #51 Adherent 6.1 1. 5
19. 50% Sephadex G-10 Nonadherent #51 (G-#51) 4. 2 1. 3
20. 40% G-#51 & 10% Normal Adherent 5.4 2. 1
21. 40% G-#51 & 10% #51 Adherent 6.6 1. 7
TABLE 2: Spleen Cell Differential Counts (mean ± standard error) 
Group 
H238 Cell-injected Mice: 	(H238) 
Untreated 
Sephadex G-10 Nonadherent 	(G-H238) 
Carbonyl Fe Nonphagocytic 	(CF-H238) 










Petri Dish Adherent (H238 Adherent) 55.7±3.5 35.7±3.5 8.6±0.5 
#51 Cell-injected Mice: 	(#51) 
Untreated 82.3±4.1 16.7±3.9 1.0±0.5 
Sephadex G-10 Nonadherent 	(G-#51) 99.8±0.6 0.2±0.2 0± 	0 
Carbonyl Fe Nonphagocytic 	(CF-#51) 98.2±0.5 1.8±0.5 0± 	0 
Petri Dish Adherent 	(#51 Adherent) 93.7±3.4 3.0±1.0 3.3±2.4 
Normal: 
Untreated 93.4±0.9 5.3±1.3 1.3±0.5 
Petri Dish Adherent (Normal Adherent) 95.3±3.7 3.7±3.2 1.0±0.6 
s. I.
� 
FIGURE l: Cell Mixing· Experiment Using Spleen Cells
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FIGURE 2: Mixing Experiment Using Spleen Cells 
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FIGURE 3: Effects of Sephadex G-10 Treatment 
and Reconstitution with Adherent Cells 
on Spleen Cell Response to PHA Stimulation 
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FIGURE 4: Effect of Carbonyl Iron Treatment 
and Reconstitution with Adherent Cells 
on Spleen Cell Response to PHA Stimulation 


























FIGURE 5: Effects of Sephadex G-10 Treatment 
and Reconstitution with Adherent Cells 
in Spleen Cell Response to PHA Stimulation 
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FIGURE 6: Effects of Carbonyl Iron Treatment 
and Reconstitution with Adherent Cells 
on Spleen Cell Response to PHA Stimulation 
in the #51 System 
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